Citalopram Hydrobromide Tablets

The main ingredient of this product is Citalopram hydrobromide, chemical name: 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile, hydrobromide.

Depressive disorders (endogenous and non-endogenous depression).

Adults: Take Citalopram Hydrobromide Tablets once daily. The initial dose is 20 mg per day. If clinically necessary, it can be increased to 40 mg per day or a maximum dose of 60 mg per day. Elderly patients (65 years old): For patients over 65 years old, the maximum daily dose is 40 mg. Antidepressant treatment is symptomatic and must be continued for an appropriate period of time. Generally, 4-6 months are required for manic-depressive mental disorders. If insomnia or severe akathisia occurs, sedatives are recommended in the acute phase. Children and adolescents (<18 years old): This product is not suitable for children and adolescents under 18 years old. Patients with reduced renal function: No dose adjustment is required for patients with mild to moderate reduced renal function. There is no data for patients with severe reduced renal function (CLCR<20ml/minute). Patients with reduced liver function: It is recommended that the daily dose for patients with reduced liver function should not exceed 30 mg. Or follow the doctor's advice.

The side effects observed with Citalopram Hydrobromide are usually few, mild and transient. The most common adverse reactions are: nausea, increased sweating, decreased salivation, headache and shortened sleep time. They are usually more obvious in the first or second week of treatment and generally disappear gradually as the depressive state improves. Seizures have been observed in rare cases. In patients with pre-existing bradycardia, bradycardia can complicate treatment.

It is contraindicated to use in combination with monoamine oxidase inhibitors; it is contraindicated for those who are allergic to this product and/or any of its ingredients.

Concomitant use of monoamine oxidase inhibitors may result in hypertensive crisis.

Store at room temperature below 25°C.

20 mg

60 months.